Dr Rewena Keegan

Dr Rewa Keegan is a Consultant Breast Specialist and internationally board-certified Lifestyle Medicine Physician. A Fellow of the Royal Australasian College of Surgeons, she integrates surgical expertise with evidence-based nutrition, behaviour change, and preventative care. Dr Keegan has a special interest in supporting breast cancer survivors through holistic, lifestyle-focused approaches. She is the founder of ReVital Lifestyle Medicine and a frequent speaker on women’s health and wellbeing.

Dr Mike Lin

Mike is a Consultant Endocrinologist and Staff Specialist at Royal Prince Alfred Hospital, Sydney, and a PhD Candidate at the Garvan Institute of Medical Research and St Vincent’s Clinical School of Medicine. He has a clinical and academic focus on metabolic bone disease, with his doctoral research centred on optimising osteoporosis treatment strategies in individuals with multimorbidity.

Dawid Naud

Dawid Naude is a trailblazer in business, disruption, and innovation, shaping the future by translating AI’s potential into real world impact. Committed to making AI exciting, accessible, and impossible to ignore, he helps organisations to make every employee more productive, reimagine what’s possible, and achieve breakthrough innovation.   As the CEO and Founder of Pathfindr - Australia’s leading, AFR Award-Winning AI accelerator, Dawid is one of the country’s foremost AI innovators, educators, and implementers. With an infectious energy and a gift for making the complex feel simple, his keynotes have built a reputation for exciting audiences into action.

Lindsay Page

AI is daunting to most people, but Lindsay breaks it down so it's easy to understand and most importantly easy to use. With a background in system's design, she now is the AI Upskilling Lead at Pathfindr which was announced as one of AFR's Most Innovative Companies of 2024. Lindsay works with teams to get the most out of AI, from training them how to use off the shelf tools, to designing new ones specifically for their needs.

Prof Kelly-Anne Phillips

Professor Kelly-Anne Phillips is Co-Lead of Breast Medical Oncology at the Peter Mac. She is an NHMRC Leadership Fellow and Fellow of the Australian Academy of Health and Medical Sciences. Her research focuses on precision breast cancer prevention. She chairs the Prevention Group of the Lancet Breast Cancer Commission. She has developed two key digital enablers of precision breast cancer prevention. iPrevent (www.petermac.org/iprevent) is a free web-based breast cancer risk assessment and management tool, recommended by Cancer Australia. The Preventing Cancer with Medications Service is a novel telehealth Service that helps clinicians to prescribe medications that halve breast cancer risk.

Matthew Warner-Smith

Matthew Warner-Smith is the Manager of Business Intelligence and Information Systems at the Cancer Institute NSW and has 30 years’ experience in public health in a diverse range of government and multilateral settings. Prior to joining the Cancer Institute in 2013 Matthew worked in the United Nations system in a variety of roles, largely focused on behavioural surveillance, national capacity building in monitoring and evaluation, and health system strengthening in the fields of HIV and illicit drug use. Matthew completed his Masters of Public Health in 1997 at the University of Sydney, with a focus on international health and tobacco control.

A/Prof Nicholas Wilcken

Nicholas Wilcken is Senior Staff Specialist at the Crown Princess Mary Cancer Centre Westmead, and Associate Professor of Medicine, University of Sydney, Australia. 

He is currently the Co-ordinating Editor of the Cochrane Collaboration’s Breast Cancer Group and outgoing board member of Breast Cancer Trials (ANZ). He is a member of the Steering Committee of the Early Breast Cancer Trialists’ Collaborative Group, based in Oxford, UK.